ReviewNature reviews. Cancer2026

Enhancer and metabolic rewiring by KMT2C-COMPASS or KMT2D-COMPASS family loss in cancer creates druggable vulnerabilities.

Zibo Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.